Moderna
MRNA
$101.41
Share price
-0.58%
Change (1 day)
-29.27%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Revenue for Moderna (MRNA)
Revenue in 2023 (TTM): $6.75 B
According to Moderna 's latest financial reports the company's current revenue (TTM) is $6.75 B. In 2022 the company made a revenue of $18.87 B an increase over the years 2021 revenue that were of $17.73 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Moderna from 2018 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $6.75 B | -64.22% |
| 2022 | $18.87 B | 6.42% |
| 2021 | $17.73 B | 6364.15% |
| 2020 | $0.27 B | 471.19% |
| 2019 | $48.03 M | -60.87% |
| 2018 | $0.12 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 1,277.29% | 🇺🇸 USA |
 Novartis NVS | $51.01 B | 655.29% | 🇨🇭 Switzerland |
 Merck MRK | $60.11 B | 790.05% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | N/A | N/A | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $0.19 B | -97.14% | 🇺🇸 USA |
 Athersys ATHX | $0.08 M | -100.00% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $1.82 B | -72.93% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $0.18 B | -97.31% | 🇺🇸 USA |